Search Results

Keyword:States

FDA Approves Tauklarify, a Tau PET Imaging Agent for Alzheimer's Disease

FDA Approves Tauklarify, a Tau PET Imaging Agent for Alzheimer's Disease

The U.S. Food and Drug Administration has approved Tauklarify, a new brain imaging agent for the evaluation of Alzheimer's disease. The drug, also known as MK-6240, is a radioactive diagnostic agent for positron emission tomography (PET) in adults, primarily indicated for adults with cognitive impairment who require physician assessment of abnormal tau protein accumulation in the brain. The twisted, insoluble fibrous deposits formed by tau protein are believed to be associated with neurodegenerative diseases such as Alzheimer's disease. The developer, Lantheus, stated that the safety of Tauklarify was evaluated in two clinical trials involving more than 1,700 subjects. Adverse reactions...

2026-08-16

Function Health Secures $450 Million in Funding to Expand Laboratory Testing and Medical Imaging Platform

Function Health Secures $450 Million in Funding to Expand Laboratory Testing and Medical Imaging Platform

U.S. health technology company Function Health recently secured $450 million in growth funding from General Catalyst's Customer Value Fund. The company stated that the funds will be used to expand user coverage of its testing and medical imaging platform. Function Health launched as a beta version in 2023, with a platform integrating laboratory testing, medical imaging, and health data analytics services. Its membership includes over 160 laboratory tests, with testing scheduled twice a year, and annual plans starting at $365. Testing coverage encompasses cardiovascular health, hormones, thyroid and kidney function, inflammation, nutritional levels, and certain cancers...

2026-08-16

Society of Interventional Radiology Launches Framework to Quantify the Value of Interventional Radiology

Society of Interventional Radiology Launches Framework to Quantify the Value of Interventional Radiology

The Society of Interventional Radiology (SIR) is developing a framework to measure the clinical and economic value of interventional radiology, aiming to expand the specialty's role in health system planning, payment reimbursement, and patient management. According to reports, SIR has partnered with triLumen Health Partners to develop a strategic roadmap focused on identifying and quantifying the contributions of interventional radiology in academic medical centers, community hospitals, and outpatient settings. The project is expected to inform SIR's strategic planning extending through 2029 and beyond. Dr. Saher S. Sabri, SIR President, stated that interventional radiology is currently often evaluated using metrics such as procedure volume and relative value units, but these metrics may not fully reflect its role in long-term clinical care, perioperative management, and overall health system cost control...

2026-08-16

USTC Team Participates in STAR Experiment, Discovering Possible "Y"-Shaped Gluon Junction Inside Nucleons

USTC Team Participates in STAR Experiment, Discovering Possible "Y"-Shaped Gluon Junction Inside Nucleons

The University of Science and Technology of China, together with Kent State University and Brookhaven National Laboratory, played a leading role in the STAR international collaboration. Through precise measurements of net baryon number and net charge in high-energy nucleus-nucleus collision experiments, they discovered an exotic structure inside nucleons that may overturn fundamental understanding of nucleon internal structure. In the early morning of August 14, the results were published online in the journal Science under the title "Tracking the baryon number with nuclear collisions." Nucleons are the fundamental particles that make up the material world, carrying more than 99% of the mass of the visible matter in the universe. Understanding the internal structure of nucleons is of paramount importance for understanding the fundamental constituents and fundamental interactions of the material world.

2026-08-14

EIC and CERN Strengthen Cooperation to Advance International Scientific Exchange for the Electron-Ion Collider

EIC and CERN Strengthen Cooperation to Advance International Scientific Exchange for the Electron-Ion Collider

August 12, 2026 - The collaboration between the Electron-Ion Collider (EIC) project and the European Organization for Nuclear Research (CERN) is deepening further. On May 28, CERN hosted a workshop themed around the EIC to introduce the project's scientific goals, construction progress, and future research opportunities to its international scientific community. Luisella Lari (right), Deputy Director for Strategic Partnerships of the Electron-Ion Collider (EIC) project, poses with Matthew Chalmers, organizer of the CERN lecture series, after delivering a talk titled "The Road to the Electron-Ion Collider" at CERN. Luisella Lari, senior scientist on the EIC project, delivered a talk titled "The Road to the Electron-Ion Collider" at the workshop.

2026-08-13

US Valion Bio Initiates Safety Study of Entolimod for Radiation-Induced Gastrointestinal Injury

US Valion Bio Initiates Safety Study of Entolimod for Radiation-Induced Gastrointestinal Injury

US biotechnology company Valion Bio announced on August 12 that the safety study of its investigational therapeutic candidate Entolimod for radiation-induced gastrointestinal injury is scheduled to commence this week. The study is being advanced by the Armed Forces Radiobiology Research Institute (AFRRI) under a contract with the National Institute of Allergy and Infectious Diseases (NIAID), as part of a government-funded research program. According to the company's disclosure, Entolimod has been delivered to AFRRI, the study has received approval from the Institutional Animal Care and Use Committee (IACUC), and the experimental animals are currently in the pre-dosing acclimation phase. The safety study will confirm the tolerability of Entolimod in the animal strain used by AFRRI...

2026-08-13

ASP Isotopes Plans Commercial Delivery of Multiple Stable Isotopes in Second Half of 2026

ASP Isotopes Plans Commercial Delivery of Multiple Stable Isotopes in Second Half of 2026

ASP Isotopes Inc. recently presented its expansion plans for isotope production, radiopharmaceuticals, and helium operations at Canaccord Genuity's 46th Annual Growth Conference. The company aims to begin commercial delivery of stable isotopes including silicon-28, carbon-14, and ytterbium-176 in the second half of 2026. Victor Petkov, the company's Chief Commercial Officer, stated that ASP Isotopes is leveraging its proprietary enrichment technology to serve electronics, nuclear medicine, and nuclear fuel-related markets. Currently, the company operates three production facilities in Pretoria, South Africa, primarily producing silicon-28 for semiconductor applications, as well as carbon-14 and ytterbium-176 for nuclear medicine-related uses. Regarding isotope supply...

2026-08-13

American Society for Radiation Oncology Foundation to Award $2.4 Million in Grants to 14 Researchers

American Society for Radiation Oncology Foundation to Award $2.4 Million in Grants to 14 Researchers

The American Society for Radiation Oncology (ASTRO) Foundation will award a total of $2.4 million in research grants to 14 scientists dedicated to advancing patient care in radiation medicine. ASTRO stated that the 2026 awards are the first annual grants issued since the society renamed its foundation to LightSpeed—ASTRO Foundation earlier this year. The rebranded foundation will focus on accelerating relevant research and strengthening workforce development in the field of radiation oncology. This round of funding is co-sponsored by the American Cancer Society, the American Association of Physicists in Medicine, the Breast Cancer Research Foundation, the LUNGevity Foundation, and the Prostate Cancer Foundation. ASTRO CEO Vive...

2026-08-13

U.S. Company Proposes Americium-241 Radioisotope Heating Solution for Spacesuits, Receives Early NASA Research Support

U.S. Company Proposes Americium-241 Radioisotope Heating Solution for Spacesuits, Receives Early NASA Research Support

U.S.-based Zeno Power Systems has proposed a radioisotope heating concept for lunar extravehicular activities, planning to use Americium-241 (Am-241) to provide continuous passive warmth for astronauts during lunar nights and in permanently shadowed regions. The proposal has been selected for this year's NASA Innovative Advanced Concepts (NIAC) program, with the potential to receive up to $175,000 in early-stage research funding. The lunar surface environment is one of the key challenges for long-duration crewed missions. Data shows that lunar nights can last approximately two weeks, and extreme low temperatures will limit the duration of astronaut extravehicular activities in shadowed areas and at night. Even with new-generation spacesuits, their cold resistance remains limited...

2026-08-13

Texas to Accelerate Opening of Sterile Fly Facility to Combat New World Screwworm Outbreak

Texas to Accelerate Opening of Sterile Fly Facility to Combat New World Screwworm Outbreak

The U.S. Department of Agriculture announced that, in response to the New World screwworm (NWS) outbreak already detected in Texas and New Mexico, the sterile fly facility at Moore Air Base in Edinburg, Texas, will open early next spring, approximately seven months ahead of the original schedule. Construction on the facility began in April of this year, and once completed, it will produce sterile flies to support outbreak control efforts using the Sterile Insect Technique (SIT). Under the plan, the facility will reach full operational capacity by the end of 2028, producing approximately 300 million sterile flies per week. The Sterile Insect Technique works by releasing sterilized flies into the environment to mate with wild screwworms, thereby interrupting the reproductive cycle and reducing the risk of continued parasite spread...

2026-08-12

University of Missouri Receives $1 Million Grant to Research New FLASH Radiotherapy System

University of Missouri Receives $1 Million Grant to Research New FLASH Radiotherapy System

On August 11, researchers at the University of Missouri School of Medicine received a $1 million grant from the National Institutes of Health to study a new technology in cancer radiotherapy—the TheryQ FLASHKNiFE system. The project is funded through June 2027. A long-standing challenge in cancer treatment is how to kill tumor cells while protecting surrounding healthy tissue as much as possible. Existing radiotherapy can already achieve millimeter-level precision, but radiation damage and related side effects still limit the dose patients can safely receive. Unlike conventional approaches, FLASH radiotherapy does not primarily alter the direction of radiation beams, but instead delivers irradiation in an extremely short time at an ultra-high dose rate...

2026-08-12

US Oak Ridge National Laboratory Restarts Tungsten-188/Rhenium-188 Generator Production to Support Targeted Cancer Therapy Research

US Oak Ridge National Laboratory Restarts Tungsten-188/Rhenium-188 Generator Production to Support Targeted Cancer Therapy Research

The US Department of Energy's Oak Ridge National Laboratory (ORNL) recently restarted and upgraded its tungsten-188/rhenium-188 (W-188/Re-188) generator manufacturing operations to meet the demand for the rare medical isotope rhenium-188 in targeted cancer therapy research. The laboratory last manufactured such generators in 2011. Radiochemist Becca Hores demonstrated the assembly process of the W-188/Re-188 generator. Depending on radioactivity levels, these generators must be assembled in gloveboxes or hot cells. Image credit: Maggie Gregg/Oak Ridge National Laboratory, US Department of Energy. Rhenium-188 is produced by the radioactive decay of tungsten-188. ORNL irradiates tungsten-186 in the High Flux Isotope Reactor (HFIR) to produce tungsten-188...

2026-08-12

CT "5-Star" Image Quality Scoring May Help Reduce Radiation Dose

CT "5-Star" Image Quality Scoring May Help Reduce Radiation Dose

A multinational study involving the International Atomic Energy Agency and Massachusetts General Hospital in the United States shows that a standardized 5-star scoring system that considers both radiation dose and CT image quality can produce relatively consistent evaluations across different radiologists and help identify opportunities to reduce patient radiation exposure. This retrospective study included 2,737 adult CT examinations performed at 6 hospitals across 5 European countries, including 1,247 chest CTs and 1,490 abdominal CTs, involving 13 CT scanners. At each hospital, 3 radiologists independently evaluated the examinations using the 5-star framework. Unlike traditional image quality assessments that may favor lower noise...

2026-08-12

Flammable Gas Analysis Completed for Legacy Transuranic Waste Containers at U.S. Savannah River Site

Flammable Gas Analysis Completed for Legacy Transuranic Waste Containers at U.S. Savannah River Site

AIKEN, South Carolina — The Solid Waste and Deactivation and Decommissioning team at Savannah River Nuclear Solutions (SRNS) recently completed a critical task, performing flammable gas analysis on multiple legacy high-dose-rate transuranic (TRU) waste containers. The results confirmed that these containers meet safety requirements for shipment to an underground waste disposal facility. Following this analysis, the U.S. Department of Energy Office of Environmental Management will resume shipments of remote-handled transuranic waste drums from the Savannah River Site (SRS) to the Waste Isolation Pilot Plant (WIPP) in New Mexico for permanent disposal. Flammable gas sampling is an important safety step prior to the transportation and disposal of transuranic waste. Workers...

2026-08-11

Brookhaven National Laboratory Pilots Training Program for Nuclear Technology and Radiochemistry Talent

Brookhaven National Laboratory Pilots Training Program for Nuclear Technology and Radiochemistry Talent

The U.S. Department of Energy's Brookhaven National Laboratory and Suffolk County Community College (SUNY Suffolk) recently completed a pilot program to train talent in nuclear technology and radiochemistry. Eleven students and recent graduates completed one semester of coursework and three weeks of intensive laboratory training, becoming the first cohort to complete the Nuclear Technology and Radiochemistry Technician Pathway (NTRTP) program. SUNY Suffolk student Arin Morton (left) works under the guidance of mentor Michael Chimes at Brookhaven National Laboratory's Isotope Research and Production Division...

2026-08-11

Baidu
map